Physician profile
Thomas J Davis
NPI 1548320161
$1,760.36
in general payments reported to CMS, 2019-2025
21 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $166 · 2021: $163 · 2022: $238 · 2023: $329 · 2024: $224 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $367.34 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $198.57 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $175.89 | 2019-2021 | |
| Lilly USA, LLC | $174.94 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Abbvie INC. | $135.64 | 2021-2025 | Vraylar, Linzess, Viberzi |
| Astrazeneca Pharmaceuticals LP | $106.31 | 2019-2025 | Breztri, Farxiga |
| Mylan Specialty L.P. | $89.16 | 2019-2022 | |
| Amgen INC. | $67.33 | 2022-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $58.51 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.87 | 2021-2023 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $53.90 | 2019-2023 | |
| Pfizer INC. | $44.83 | 2019-2023 | |
| Abbott Laboratories | $35.14 | 2022-2023 | Freestyle Libre 3 |
| Esperion Therapeutics, INC. | $33.65 | 2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.51 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $31.83 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $27.52 | 2022-2023 | Seglentis, Livalo |
| Collaborative Care Diagnostics, LLC | $23.60 | 2019 | |
| Exact Sciences Corporation | $18.97 | 2023 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $16.06 | 2025 | Fanapt |
| Amarin Pharma, INC. | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.